Risk Assessment on Use of Lactobacillus rhamnosus (LGG) as an Ingredient in Infant Formula and Baby Foods (II)

By:
Espen Rimstad, Lene Frost Andersen, Wenche Frølich, Livar Frøyland, Ernst Arne Høiby, Georg Kapperud, Margaretha Haugen, Jørgen Lassen, Bjørn-Tore Lunestad, Helle Margrete Meltzer, Judith Narvhus, Truls Nesbakken, Karin Nygård, Ørjan Olsvik, Jan Erik Paul
Date:
2024
Resource type:
Blogs/news/opinion
Link:

Summary: This risk assessment evaluates the safety of Lactobacillus rhamnosus GG (LGG) in infant formulas. While LGG may have short-term benefits for diarrhea, its long-term effects on gut microbiota and immune health remain uncertain, particularly for daily use in infants. The study finds no substantial evidence to support its prophylactic benefits for infants aged 4 months to 3 years and emphasizes the need for more rigorous long-term studies to determine safety and efficacy.

source: canva